Modified endotracheal tubes designed to cut back affected person pneumonia threat failed to enhance outcomes in comparison with normal respiration tubes, new Lancet analysis studies.
Polyurethane-cuffed endotracheal tubes with subglottic suction (PU-EVAC) didn’t cut back incidence of IVAC or doable VAP in contrast with a typical PVC endotracheal tube with no subglottic drainage, in response to outcomes of the randomized managed part 2 trial referred to as PreVent2 printed in Lancet Respiratory Medication.
Ventilator-associated pneumonia (VAP) is a harmful lung an infection related to worse high quality of life, cognitive operate, and common well being outcomes. The tubes examined on this examine, referred to as PU-EVAC, try to cut back pneumonia threat by changing standard polyvinylchloride (PVC) cuffs with extra leakproof polyurethane cuffs, and including a built-in suction port to maintain fluids from leaking into sufferers’ airways.
Within the trial, 1,068 grownup sufferers with acute respiratory failure have been intubated both with the specialised PU-EVAC tube, or with a typical, PVC endotracheal tube.
Researchers discovered related charges of suspected pneumonia (6% within the PU-EVAC group vs. 5% within the PVC group) and general infections (8% within the PU-EVAC group vs. 6% within the PVC group),and reported no vital variations in throat harm threat or long-term restoration.
“Sufferers requiring emergency intubation for respiratory failure are vulnerable to a number of issues, together with ventilator related pneumonia” mentioned Miriam Treggiari, MD, professor of anesthesiology at Duke College Faculty of Medication and principal investigator of the examine. “Stopping these probably severe issues is a excessive administration precedence,” Treggiari provides, “however it’s clear from this trial that the reply doesn’t lie with polyurethane cuffs and subglottic secretion drainage.
Polyurethane-cuffed endotracheal tubes with subglottic suction (PU-EVAC) didn’t cut back incidence of IVAC or doable VAP in contrast with a typical PVC endotracheal tube with no subglottic drainage. At 6-month follow-up, neither high quality of life, cognitive operate, nor laryngeal harm differed between teams. Nevertheless, the small variety of survivors who offered info on their bodily and psychological standing limits the conclusions that may be drawn concerning long-term end result variations.1
1Supply: Lancet Respiratory Medication
The examine represents essentially the most in-depth trial of the specialised respiration tubes thus far, as tips proceed to evolve. “The CDC and the Society for Healthcare Epidemiology of America have been recommending PU-EVAC on the premise of prior trials and meta-analyses to cut back pneumonia, length of ICU keep and air flow,” mentioned Emily Sharp, PhD, Affiliate Professor of Neurology at Yale Faculty of Medication, was the trial’s website principal investigator at Yale.
“Whereas latest tips downgraded the advice in 2022, this examine affirms the shortage of good thing about PU-EVAC endotracheal tubes and underscores the excessive morbidity, mortality, and long-term cognitive challenges amongst sufferers requiring emergency intubation for acute respiratory failure.”
